Tuesday, August 16, 2022 | Back issues
Courthouse News Service Courthouse News Service

Pharma Class Action

WILMINGTON, Del. - Directors of Medicis Pharmaceutical Corp. are selling the company too cheaply through an unfair process to Valeant Pharmaceuticals, for $44 a share or $2.6 billion, shareholders claim in Chancery Court.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.

Loading
Loading...